UNSPSC 51413907: Manozodil

This classification denotes a vasodilating agent with the molecular formula C10H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GZM2484VQ4, chemically known as 4,5,6,7-tetrahydro-2-methyl-5-((methylamino)methyl)benzothiazole but generally known as manozodil, which bears US NIH Compound Identifier 72110. European Medicines Agency schedules Manozodil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08645MIG. The term MANOZODIL is an International Non-Proprietary Name.

UNSPSC 51413907 Manozodil is a Commodity code for emergency medical medications supplied to state and local public safety agencies. State and local governments procure advanced life support medications—epinephrine, labetalol, adenosine, diltiazem, and related emergency-response pharmaceuticals—for fire rescue services, emergency medical services, and hospital systems under this code. Issuing bodies are primarily city fire and rescue departments and county emergency services; the recent solicitation activity shows city purchasing offices coordinating acquisitions on behalf of fire-rescue operational units. Vendors supply these medications in specific unit quantities to meet paramedic and emergency-response protocols, with strict expiration-date requirements (typically nine months or more from acceptance) and rapid delivery windows (commonly ten calendar days or less from order receipt).

The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for Advanced Life Support Medications to support Tampa Fire Rescue in Hillsborough County, Florida, requesting 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with delivery within ten calendar days. The bid response deadline was April 8, 2026, with contract award within 120 days to the lowest responsive, responsible bidder; the estimated contract value was $40,000.00 and included a one-year initial term with two optional one-year renewals. The solicitation included a 5 percent SLBE bid discount (not to exceed $10,000) and required vendors to submit comprehensive accessibility documentation per WCAG 2.2 Level AA and Section 508 standards, plus OSHA-compliant Safety Data Sheets for all medications. This is the only recent opportunity visible in the state and local market under this code.